Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 15 | 2024 | 1022 | 1.130 |
Why?
|
| Tachycardia, Ventricular | 4 | 2024 | 196 | 0.570 |
Why?
|
| Catheter Ablation | 4 | 2024 | 229 | 0.560 |
Why?
|
| Ventricular Function, Left | 3 | 2015 | 500 | 0.530 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2013 | 78 | 0.470 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2013 | 18 | 0.420 |
Why?
|
| Shock, Cardiogenic | 2 | 2012 | 189 | 0.410 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 111 | 0.390 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 152 | 0.350 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 624 | 0.340 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2023 | 189 | 0.320 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2020 | 425 | 0.320 |
Why?
|
| Heart Failure | 6 | 2022 | 2125 | 0.310 |
Why?
|
| Aortic Valve Stenosis | 2 | 2023 | 322 | 0.300 |
Why?
|
| Respiratory Insufficiency | 2 | 2023 | 234 | 0.290 |
Why?
|
| Prosthesis Implantation | 3 | 2015 | 144 | 0.270 |
Why?
|
| Heart Aneurysm | 1 | 2006 | 38 | 0.260 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 38 | 0.210 |
Why?
|
| Pacemaker, Artificial | 1 | 2023 | 170 | 0.180 |
Why?
|
| Plasmapheresis | 1 | 2019 | 29 | 0.170 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 475 | 0.150 |
Why?
|
| Heparin | 1 | 2019 | 229 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2020 | 457 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 230 | 0.150 |
Why?
|
| Treatment Outcome | 9 | 2023 | 12045 | 0.140 |
Why?
|
| Reoperation | 1 | 2020 | 807 | 0.140 |
Why?
|
| Epicardial Mapping | 1 | 2015 | 3 | 0.130 |
Why?
|
| Humans | 28 | 2024 | 122296 | 0.120 |
Why?
|
| Thrombosis | 1 | 2019 | 515 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 31 | 0.110 |
Why?
|
| Retrospective Studies | 10 | 2024 | 15853 | 0.110 |
Why?
|
| Transposition of Great Vessels | 1 | 2015 | 131 | 0.110 |
Why?
|
| Aged | 10 | 2024 | 18785 | 0.110 |
Why?
|
| Electrocardiography | 3 | 2015 | 963 | 0.110 |
Why?
|
| Middle Aged | 13 | 2024 | 25640 | 0.100 |
Why?
|
| Fontan Procedure | 1 | 2015 | 182 | 0.100 |
Why?
|
| Hemodynamics | 2 | 2015 | 839 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 86 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 430 | 0.100 |
Why?
|
| Male | 17 | 2024 | 59522 | 0.100 |
Why?
|
| Aortic Valve | 3 | 2023 | 426 | 0.090 |
Why?
|
| Female | 15 | 2024 | 64883 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 606 | 0.090 |
Why?
|
| Heart Transplantation | 2 | 2015 | 853 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2020 | 2997 | 0.080 |
Why?
|
| Risk Factors | 6 | 2022 | 9902 | 0.080 |
Why?
|
| Survival Rate | 4 | 2018 | 1997 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2024 | 1008 | 0.080 |
Why?
|
| Sarcoidosis | 1 | 2009 | 63 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2013 | 482 | 0.080 |
Why?
|
| Eisenmenger Complex | 1 | 2008 | 5 | 0.080 |
Why?
|
| Endothelin B Receptor Antagonists | 1 | 2008 | 4 | 0.080 |
Why?
|
| Endothelin A Receptor Antagonists | 1 | 2008 | 9 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2009 | 123 | 0.070 |
Why?
|
| Mitral Valve Stenosis | 1 | 2008 | 34 | 0.070 |
Why?
|
| Isoxazoles | 1 | 2008 | 31 | 0.070 |
Why?
|
| Cardiac Tamponade | 1 | 2008 | 37 | 0.070 |
Why?
|
| Heart Ventricles | 2 | 2017 | 767 | 0.070 |
Why?
|
| Thiophenes | 1 | 2008 | 60 | 0.070 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2008 | 63 | 0.070 |
Why?
|
| Echocardiography | 1 | 2013 | 1066 | 0.070 |
Why?
|
| Cor Triatriatum | 1 | 2007 | 11 | 0.070 |
Why?
|
| Exercise Test | 1 | 2008 | 247 | 0.070 |
Why?
|
| Calcinosis | 1 | 2008 | 167 | 0.070 |
Why?
|
| Myocarditis | 1 | 2007 | 119 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2008 | 258 | 0.060 |
Why?
|
| Incidence | 3 | 2018 | 3018 | 0.060 |
Why?
|
| Time Factors | 4 | 2022 | 6182 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 392 | 0.060 |
Why?
|
| Oxygen | 1 | 2008 | 549 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 517 | 0.060 |
Why?
|
| Mitral Valve | 1 | 2006 | 245 | 0.060 |
Why?
|
| Radiography | 1 | 2006 | 804 | 0.050 |
Why?
|
| Adult | 6 | 2023 | 28733 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1099 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 5013 | 0.050 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2023 | 112 | 0.050 |
Why?
|
| Patient Selection | 2 | 2016 | 685 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2015 | 665 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6291 | 0.050 |
Why?
|
| Texas | 2 | 2022 | 3528 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2023 | 453 | 0.050 |
Why?
|
| Hospitals | 1 | 2022 | 397 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2018 | 122 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2020 | 364 | 0.040 |
Why?
|
| United States | 2 | 2018 | 10487 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2008 | 113 | 0.030 |
Why?
|
| Equipment Design | 1 | 2018 | 596 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 1799 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1476 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2022 | 841 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2019 | 582 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 336 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 8760 | 0.030 |
Why?
|
| Heart Rate | 1 | 2015 | 584 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 749 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1247 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 1413 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 810 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1490 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2080 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1362 | 0.020 |
Why?
|
| Disease Management | 1 | 2013 | 511 | 0.020 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2009 | 57 | 0.020 |
Why?
|
| Syncope | 1 | 2009 | 52 | 0.020 |
Why?
|
| Aortography | 1 | 2009 | 200 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2009 | 169 | 0.020 |
Why?
|
| Microspheres | 1 | 2008 | 70 | 0.020 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2008 | 42 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 2008 | 57 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 215 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 3307 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 352 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 729 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 182 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 269 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2008 | 668 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2007 | 241 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 172 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 1246 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1679 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 5963 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 1314 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 18940 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 2030 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 3448 | 0.010 |
Why?
|